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Purpose: To assess the effects of polysaccharide extract from Spirulina platensis (PSP) on corneal neovascularization
(CNV) in vivo and in vitro.
Methods: PSP was extracted from dry powder of Spirulina platensis. Its anti-angiogenic activity was evaluated in the
mouse corneal alkali burn model after topical administration of PSP four times daily for up to seven days. Corneal samples
were  processed  for  histochemical,  immunohistochemical,  and  gene  expression  analyses.  The  effects  of  PSP  on
proliferation,  migration,  tube  formation,  and  serine  threonine  kinase  (AKT)  and  extracellular  regulated  kinase1/2
(ERK1/2) signaling levels in vascular endothelial cells were determined using 3-(4,5)-dimethylthiahiazo (-z-y1)-3, 5-di-
phenytetrazoliumromide (MTT) and carboxyfluorescein succinimidyl ester (CFSE) labeling assays, wound healing assay,
Matrigel tube formation assay, and western blot.
Results: Topical application of PSP significantly inhibited CNV caused by alkali burn. Corneas treated with PSP showed
reduced levels of platelet endothelial cell adhesion molecule (CD31) and stromal cell-derived factor 1 (SDF1) proteins,
reduced  levels  of  vascular  endothelial  growth  factor  (VEGF),  matrix  metalloproteinase-2  (MMP2),  matrix
metalloproteinase-9 (MMP9), SDF1, and tumor necrosis factor-alpha (TNF-α) mRNAs, and an increased level of pigment
epithelium-derived factor (PEDF) mRNA. These are parameters that have all been related to CNV and/or inflammation.
In human vascular endothelial cells, PSP significantly inhibited proliferation, migration, and tube formation in a dose-
dependent manner. Furthermore, PSP also decreased the levels of activated AKT and ERK 1/2.
Conclusions: These data suggest that polysaccharide extract from Spirulina platensis is a potent inhibitor of CNV and
that it may be of benefit in the therapy of corneal diseases involving neovascularization and inflammation.
Under  normal  physiologic  conditions,  corneal  tissue
maintains its avascular transparent characteristics [1,2]. The
molecular basis of the cornea’s avascularity has been shown
to be the presence of soluble vascular endothelial growth
factor (VEGF) receptor 1 [2], nonvascular VEGF receptor 3
expressed by corneal epithelium [3], the balance between
angiogenesis  promoting  factors  (such  as  VEGF)  and
inhibiting factors (such as pigment epithelium-derived factor
[PEDF]) [4,5], and the systemic distributions and molecular
interactions of VEGF and soluble vascular endothelial growth
factor receptor 1 (sVEGFR1) [6], which was clarified well in
the latest review of Qazi et al. [7]. Corneal neovascularization
(CNV) is a major, sight-threatening complication of some
ocular  disorders.  It  can  result  from  corneal  infections,
chemical injury, stromal ulceration, aniridia, and limbal stem
cell deficiency. CNV not only interferes with normal corneal
wound healing but also affects corneal graft survival after
keratoplasty  [1,4,8,9].  CNV  results  from  an  imbalance
between angiogenic and anti-angiogenic factors [4]. It has
been shown that CNV involves over-proliferation, migration,
and  capillary  tube  formation  by  endothelial  cells  [10].
Moreover, CNV, including that induced by alkali burn, is
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accompanied by abnormal matrix metalloproteinase activity
and  excess  inflammation.  Chemokines,  which  are  crucial
mediators  of  inflammatory  and  immune  responses,  also
contribute to multiple aspects of CNV [11,12]. Therapeutic
agents that antagonize multiple targets are therefore likely to
be of benefit in the treatment of CNV-related diseases.
Spirulina is an unbranched, helicoidal, filamentous blue-
green algae of the family Oscillatoriaceae. Spirulina has long
been used in several countries as a supplement in human and
animal food either as a health drink or in tablet form because
of its alimentary value [13]. Toxicological studies [14] have
shown  that  spirulina  is  safe  for  human  consumption.  In
addition to its special alimentary benefits, researchers are
currently turning attention to its potential usefulness in health
care and clinical applications [15,16]. Several reports have
shown  that  spirulina  possesses  anti-inflammatory  [17],
immunosuppressive [18,19], antioxidant [20], radioprotective
[21], and renoprotective [22] properties.
In  this  study,  we  investigated  the  effects  of
polysaccharide  extract  from  Spirulina  platensis  on  CNV
caused by alkali burn in mice as well as its anti-angiogenic
effects on human vascular endothelial cells. The results show
that  PSP  exhibits  anti-angiogenic  and  anti-inflammatory
properties in vivo and in vitro and suggest that PSP may be a
novel natural agent for prevention and cure of inflammatory
CNV-related diseases.
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1951METHODS
Preparation  of  polysaccharide  extract  from  Spirulina
platensis:  Polysaccharides  were  extracted  from  Spirulina
platensis  as  described  previously.  Briefly,  dried  Spirulina
platensis was soaked in 95% (v/v) ethanol overnight and then
torrefied. The mass was resuspended in NaOH (pH 10.0)
solution and incubated at 80 °C for 4–6 h. After removal of
debris by centrifugation, the liquid phase was collected and
adjusted  to  pH  7.0  followed  by  precipitation  with  5%
trichloroacetic acid (TCA) at 4 °C overnight. The mixture was
centrifuged, and the supernatant was precipitated with 5%
TCA for another 3 h. After centrifugation, the supernatant was
precipitated with ethanol (1 volume of supernatant/5 volume
of  ethanol)  at  4  °C  overnight.  The  precipitate,  mainly
containing  Spirulina  polysaccharides  (PSP),  was  washed
twice with acetone, lyophilized in a freeze-dryer, and stored at
−20 °C. Before use, the PSP preparation was dissolved in
normal saline and filtered through a 0.22 μm pore filtration
membrane. The concentration of stock polysaccharides was
measured using the anthrone-sulfuric acid method and was
adjusted to 100 μg/ml using compound sodium chloride eye
drops (Nanjing LiYe Pharmceutical Co. Ltd, Nanjing, China).
Evaluation of alkali-induced corneal neovascularization: All
animal experiments were performed in accordance with the
guidelines  of  the  Association  for  Research  in  Vision  and
Ophthalmology  Statement  for  the  Use  of  Animals  in
Ophthalmic and Vision Research. The alkali-induced CNV
mouse model was generated by direct application of 3 μl of 1
N NaOH to both eyes of the mice for 30 s under general
anesthesia with intraperitoneal ketamine and chlorpromazine.
The burned eyes were then immediately rinsed with 20 ml of
normal saline. PSP eye drops were applied topically (5 μl) to
the burned eyes four times daily for seven consecutive days.
Control  animals  were  treated  topically  with  compound
TABLE 1. PRIMERS USED FOR REAL-TIME PCR
Gene Forward primer Reverse primer Product size (bp)
VEGF GAGCAGAAGTCCCATGAAGTG CATGGTGATGTTGCTCTCTGA 213
MMP2 CCCGATCTACACCTACACCAA AAACCGGTCCTTGAAGAAGAA 217
MMP9 CGTCGTGATCCCCACTTACTA AAGATGAACGGGAACACACAG 237
SDF1 CAGTCAGCCTGAGCTACCGA TCTTCAGCCGTGCAACAATC 126
TNF-α AAGGGATGAGAAGTTCCCAAAC CCTTGTCCCTTGAAGAGAACC 264
PEDF GGTGCAGGCCCAGATGAA ACGCCAAGGAGAAGGATGCT 81
RPL5 GGAAGCACATCATGGGTCAGA TACACATCTTCATCTTCCTCCATT 70
The primer sequence and product size of the primers used in this study were provided in the table.
Figure 1. Macroscopic observation of corneal neovascularization in PSP-treated and control mice. PSP (100 μg/ml) or solvent control was
used topically 4 times everyday on alkali-injured mice cornea for 7 days, images were taken with slit lamp. It can been seen clearly that in
control group without PSP treated, the new vessel is predominant in conea, however which is very slight in cornea treated with PSP.
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1952sodium chloride eye drops without PSP. Eight mice were used
for each group. On day 7, eyes were photographed under a
slit-lamp,  and  CNV  was  quantified  using  a  method  for
determining  corneal  angiogenesis  [23].  All  mice  were
sacrificed,  and  their  eyes  were  collected  for  further
examination.
Immunohistochemistry:  Eyeballs  were  either  fixed  with
formalin or snap-frozen in optimal cutting temperature (OCT)
compound (Sakura Finetechnical, Tokyo, Japan). Formalin-
fixed,  paraffin-embedded  serial  sections  (4  μm)  were
deparaffinized by sequential washing with xylene followed by
washing with descending series of ethanol and were then
processed for hematoxylin and eosin (H&E) staining. For
immunofluorescence  staining,  cryosections  (6  μm)  were
prepared from OCT-embedded eyeballs and were fixed in ice-
cold acetone for 10 min. The sections were blocked with 10%
normal goat serum for 15 min and stained with phycoerythrin
(PE)-conjugated  anti-CD31  monoclonal  antibody  (mAb)
(1:100;  BD  Biosciences  Pharmingen,  San  Diego,  CA)  or
mouse anti- stromal cell-derived factor 1 (SDF1) mAb (1:50;
Santa Cruz Biotechnology, Inc., Santa Cruz, CA) overnight at
4 °C. Sections for SDF1 staining were washed and stained for
30 min at 37 °C with rhodamine-conjugated goat anti-mouse
immunog|obulin G (IgG) secondary antibody (1:100; Santa
Cruz).  After  counterstaining  with  4,6-diamidino-2-
phenylindole (DAPI), the stained sections were viewed under
an  Eclipse  TE2000-U  microscope  (Nikon,  Tokyo,  Japan).
Negative  controls  were  performed  by  omitting  primary
antibodies.
Real time reverse transcription polymerase chain reaction:
Total  RNA  from  mouse  corneas  was  extracted  using  a
NucleoSpin RNA II kit (Macherey-Nagel, Düren, Germany)
and reverse transcribed using a PrimeScript RT Reagent kit
(Takara,  Shiga,  Japan)  following  the  manufacturers'
instructions. Quantitative polymerase chain reaction (PCR)
was  performed  using  the  SYBR  green  method  with  Real
Master Mix SYBR Green (Tiangen Biotech, Beijing China).
Reactions were performed in an ABI 7500 Detection System
(Applied Biosystems, Foster City, CA) for 45 cycles at 95 °C
for 15 s and at 60 °C for 60 s after initial incubation for 10 min
at 95 °C. Gene-specific Ct values were standardized based on
ribosomal protein L5 (RPL5) Ct values obtained for each
cDNA. Each sample included triplicate sets, and the mean
values of which were used to calculate the ratios of specific
mRNA levels. The dissociation curve for each amplification
reaction was generated to confirm the absence of nonspecific
amplification. Gel electrophoresis was used to determine that
amplified  products  were  of  the  expected  sizes.  Specific
primers used in this study are listed in Table 1.
Cell proliferation assay: Human umbilical vein endothelial
cells (HUVECs, ATCC CRL-1730) were used for in vitro
analyses. Cell proliferation was measured using both 3-(4, 5)-
dimethylthiahiazo  (-z-y1)-3,  5-di-  phenytetrazoliumromide
(MTT)  and  carboxyfluorescein  succinimidyl  ester  (CFSE)
labeling assays. For MTT assays, HUVECs were incubated in
a medium with 0, 1, 5, 10, 50, or 100 μg/ml of PSP for 72 h
followed by 4 h incubation with MTT. The MTT transformed
crystals were dissolved in dimethyl sulfoxide, and absorbance
at 490 nm was measured using a microplate reader (Molecular
Devices,  Sunnyvale,  CA).  Cell  proliferation  was  also
measured  using  the  CFSE  labeling  assay  as  previously
described [24]. CFSE is used to fluorescently label live cells
and is equally partitioned to daughter cells during division and
Figure  2.  Histology  of  chemically
burned corneas stained with H&E. H&E
staining shows much more new vessels
and  mononuclear  cells  presented  in
control corneal stroma compared with
PSP treated cornea. Three sections from
different  mice  are  shown  in
representative micrographs. Bar, 50 µm.
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1953can be used to measure cell proliferation. Briefly, the cells
were washed three times with PBS and incubated with 1 μM
CFSE dye (CFDA SEM Cell Tracer kit; Molecular Probes,
Eugene, OR) for 15 min. The cells were then washed again,
incubated with a fresh medium containing 10% FBS, and
seeded in six well plates at a density of 5×104 cells/well. After
24  h,  the  medium  was  replenished  with  fresh  medium
containing 0, 10, 50, or 100 μg/ml of PSP. Cells were analyzed
by flow cytometry (FACScalibur; BD Biosciences, Billerica,
MA) 72 h later. Each setting was performed in triplicate.
Cell  migration:  The  effect  of  PSP  on  the  migration  of
HUVECs was evaluated using a wound healing assay. Briefly,
the cells were plated on 24 well culture plates. A scratch was
made with a micropipette tip after confluence was reached.
Cultures were then rinsed to remove detached cells and were
incubated  for  24  h  with  a  medium  containing  various
concentrations  of  PSP  or  with  the  solvent  control.  The
scratches were photographed, and the cell migration rates
were calculated. In each group, three duplicate wells were
assayed, and each assay was conducted at least three times.
In vitro tube formation assay: Thirty microliters of Matrigel™
Matrix (BD Biosciences, Bedford, MA) was dispensed in 96
well  plates  and  allowed  to  polymerize  for  1  h  at  37  °C.
HUVECs were seeded at a density of 1.5×104 cells/well in
media containing various concentrations of PSP (0, 10, 50, or
100 μg/ml). Cultures were incubated at 37 °C for 6 h, and
digital  images  were  captured  for  the  observation  of  tube
structures.
Western blot analysis: The serine threonine kinase (AKT) and
extracellular  regulated  kinase1/2  (ERK1/2)  levels  of
HUVECs  treated  with  or  without  50  μg/ml  of  PSP  were
analyzed  using  western  blots  with  antibodies  against
Figure  3.  CD31  expression  profile  in
alkali-burned  mouse  cornea.  CD31-
positive  cells  represent  the  vessel
endothelium  cells.  The  expression  of
stromal CD31 was decreased markedly
in PSP treated cornea. Three specimens
from different mice were studied in each
group. Representative micrographs are
shown in this figure. Bar, 50 µm.
Figure 4. SDF1 expression profile in alkali-burned mouse cornea. The lymphocyte chemoattractant SDF-1 is an important inflammatory
cytokine expressed in fibroblast in cornea. Topical PSP administration decreased the expression of SDF1 in cornea stroma effectively. Three
specimens from different mice were studied in each group. Representative micrographs are shown. Bar, 50 µm.
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1954phosphorylated proteins. Briefly, cells harvested in sodium
dodecyl  sulfate-polyacrylamide  gel  electrophoresis  (SDS–
PAGE)  buffer  were  sonicated.  Protein  components  were
separated on 10% SDS–PAGE gels for 1 h at 160 V followed
by  a  transfer  to  nitrocellulose  membrane.  The  blots  were
blocked in 5% non-fat dry milk for 1 h and incubated with
primary antibody for 1 h at room temperature. After three
washes with 10 ml of Tris-buffered saline Tween-20 (TBST),
blots  were  incubated  with  a  horseradish  peroxidase-
conjugated  secondary  antibody  (Amersham  Biosciences,
Piscataway,  NJ)  and  visualized  via  enzyme-linked
chemiluminescence using the enhanced chemiluminescence
(ECL) kit (Chemicon, Temecula, CA).
Statistical analysis: Data are presented as mean±SD. The
differences between control and experimental conditions were
evaluated by SPSS 10.0 software (one-way ANOVA), and
p<0.05 was considered significant.
RESULTS
PSP inhibited corneal neovascularization in vivo: Topical
application was used to evaluate the anti-angiogenic effects
of PSP on alkali burn-induced CNV. In control mice, limbal
vessels had sprouted into central corneas seven days after
alkali burn. However, in the mice of the PSP-treated group,
only a few vessels appeared near the corneal limbal area
(Figure 1). Quantification assays showed that the average
length of vessels in the PSP-treated group was 24% of that in
the control group.
Histological H&E staining showed that the corneas of
control mice possessed more new vessels and displayed more
mononuclear cells and polymorphonuclear cell infiltration in
the corneal stroma than did corneas treated with PSP (Figure
2). The levels of vascular endothelial cells and lymphocyte
chemoattractant  cytokine  were  examined  by
immunohistochemistry  for  CD31  and  SDF1.  The  results
showed that CD31 and SDF1 were prominent in the burned
corneal stromas of control mice whereas PSP-treated corneas
exhibited negligible staining (Figure 3 and Figure 4). Real-
time PCR measurement of gene expression showed that both
angiogenesis-related  factors  (VEGF,  matrix
metalloproteinase-2 [MMP2], and matrix metalloproteinase-9
[MMP9]) and inflammation-related factors (SDF1 and tumor
necrosis factor-alpha [TNF-α]) were significantly repressed
in PSP-treated corneas compared to control corneas whereas
the anti-angiogenic factor, PEDF, was upregulated in PSP-
treated corneas when compared to the control corneas (Figure
5). The expression level of RPL5 was similar in each group.
Overall, mice treated with PSP showed markedly less severe
corneal  neovascularization  as  well  as  less  severe
inflammation and dropsy when compared with control mice
that received no therapy.
PSP inhibited the proliferation, migration, and tube formation
of  endothelial  cells:  Proliferation,  migration,  and  tube
formation by vascular endothelial cells play critical roles in
corneal  neovascularization.  We  therefore  evaluated  the
effects of PSP on the cellular properties of HUVECs in vitro.
MTT assays revealed that PSP inhibited the proliferation of
HUVECs in a dose-dependent manner. The inhibitory effect
was significant when concentrations above 10 μg/ml (p<0.05)
were applied for 72 h (Figure 6A). CFSE staining analysis
confirmed  that  the  inhibitory  effects  of  PSP  on  the
proliferation of endothelial cells were mediated by reductions
in the rate of cell division (Figure 6B). The wound healing
assay  showed  that  PSP  had  a  significant,  dose-dependent
inhibitory  effect  on  cellular  migration  (Figure  7).
Furthermore, vascular endothelial cells seeded on the surface
of  solidified  Matrigel  could  form  capillary-like  tube
structures.  When  used  above  10  μg/ml,  PSP  significantly
reduced tube formation. No tube-like structures were seen
when the PSP concentration was above 50 μg/ml (Figure 8).
PSP  inhibited  AKT  and  ERK1/2  phosphorylation  in
endothelial cells: To determine whether treatment with PSP
Figure 5. Changes in angiogenesis- and
inflammation-related  genes  in  PSP-
treated CNV corneas. Compared with
controls,  the  expressions  of  VEGF,
MMP2, MMP9, SDF1, and TNF were
reduced by 73%, 76%, 35%, 51%, and
64% respectively, while the expression
of PEDF was increased by 76%. Red
bars represent standard deviation, and
blue bars represent a 95% confidence
interval for the mean.
Molecular Vision 2009; 15:1951-1961 <http://www.molvis.org/molvis/v15/a208> © 2009 Molecular Vision
1955affects  the  signaling  of  endothelial  cells  through  AKT  or
ERK1/2 pathways, HUVECs were treated with PSP (50 μg/
ml) for 72 h and western blot assays were performed. As
shown in Figure 9, PSP significantly reduced the level of
phosphorylation  of  both  AKT  and  ERK1/2  in  HUVECs,
although it had no effect on the total amount of AKT or
ERK1/2 protein.
DISCUSSION
Ocular  neovascularization  is  closely  associated  with  local
inflammation,  and  many  chemokines  and  cytokines  are
involved in this process. Current therapies for CNV such as
surgery,  laser  photocoagulation,  and  medication  have
limitations  and  complications.  Application  of  natural
angiogenic  inhibitors  could  be  a  promising  alternative  or
possible complementary therapy in management of CNV. In
fact, several natural products with anti-angiogenic properties
have shown to affect CNV in experimental animal models.
These  agents  include  genistein  [25],  shark  cartilage  [26],
curcumin [27,28], and propolis extract [29]. In the present
study,  we  demonstrated  anti-angiogenic  and  anti-
inflammation properties of polysaccharides from Spirulina
platensis  using  the  alkali-burn  CNV  model.  We  further
confirmed  that  the  anti-angiogenic  effects  of  PSP  were
mediated by interference with the proliferation, migration,
and  tube  formation  of  vascular  endothelial  cells  in  vitro
(Figure 6,Figure 7, and Figure 8). Moreover, PSP dramatically
decreased the levels of phosphorylated AKT and ERK1/2 in
endothelial cells. Both of these protein kinases are involved
in the angiogenic process [30-35].
Several  animal  models  have  been  established  for  the
purpose of studying the role of pathologic angiogenesis in
corneal  diseases  including  corneal  micropocket,  corneal
suture,  burn  and  chemical  cornea  models,  intrastromal
injection  of  proangiogenic  factor,  and  partial  limbal
deficiency  models.  In  these  models,  chemical  corneal
treatment is often used because it closely mimics the complex
nature of the human disease and because the inflammatory
Figure 6. The effects of PSP on HUVEC
proliferation. A: MTT assay. PSP could
inhibit  HUVECs  proliferation
significantly  and  dose-dependently.
Red bars represent standard deviation,
and  blue  bars  represent  a  95%
confidence  interval  for  the  mean.  B:
CFSE  labeling  assay.  The  result
confirmed the inhibition effect of PSP
on HUVEC proliferation.
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1956response is the important component for neovascularization
in most of these models. The corneal micropocket model is
usually used to study the influence of specific molecules and
proteins in angiogenesis [36,37]. Considering the known anti-
inflammatory effects of spirulina [17] and the simulation of
human ocular disease, we selected the alkali burn induced
corneal neovascularization model to perform our study.
Topical  application  of  angiogenic  inhibitors  is  an
advantageous  route  for  prevention  and  treatment  of  CNV
because it is non-invasive and has minimal systemic adverse
effects [38-41]. The present study confirmed the effectiveness
of PSP via topical application in CNV. Topical application of
100 μg/ml PSP four times daily significantly prevented alkali
burn-induced  CNV  as  confirmed  by  morphological
observation  and  histochemical  and  immunohistochemical
staining (Figure 1, Figure 2, and Figure 3).
To detect the effects of PSP on factors responsible for
angiogenic  or  anti-angiogenic  activity,  we  first  selected
VEGF,  MMP2,  and  MMP9,  which  are  major  factors
contributing to CNV, and PEDF, a typical anti-angiogenic
factor,  for  our  study  [1,5,9].  As  shown  in  Figure  5,  PSP
suppressed the expression of VEGF, MMP2, and MMP9 and
stimulated the expression of PEDF, suggesting that PSP may
inhibit CNV by downregulating the expression of angiogenic
factors and upregulating the expression of the anti-angiogenic
factor.
For the detection of possible anti-inflammatory effects of
PSP on alkali-burned corneas, the inflammation factors SDF1
and  TNF-α  were  selected  for  study.  The  SDF1/CXCR4
ligand/receptor pair is an important contributor to several
types of ocular neovascularization [42]. TNF-α is known to
be one of the key regulators of inflammation and can mediate
angiogenesis  [43].  In  corneas,  the  infiltration  of  SDF1-
Figure  7.  The  effects  of  PSP  on  the
migration of HUVECs. Representative
photographs  of  migrating  cells  in
corneas that received either control or
PSP treatment are shown in the upper
panel. In the lower panel, the migration
rate in the control group was arbitrarily
set at 100%.
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1957positive inflammatory cells (Figure 4) and the expression of
SDF1  and  TNF-α  RNA  (Figure  5)  were  significantly
depressed by PSP. In addition, we demonstrated through in
vitro studies that PSP had significant inhibitory effects on
HUVEC proliferation, migration, and tube formation ability
(Figure 6, Figure 7, and Figure 8), which are the three key
events that contribute to CNV. We propose that PSP inhibited
CNV by directly interfering with endothelial cell behavior and
by indirectly inhibiting production of inflammatory factors
that regulate angiogenic properties.
In this assay, we found PSP treatment could dramatically
decrease the amount of phosphorylated AKT and ERK1/2 in
HUVECs, implying that the potential molecular mechanism
of PSP inhibition of CNV may be partly attributed to its
inhibition  effect  on  the  activation  of  AKT  and  ERK1/2
phosphorylation.  However,  PSP  may  also  regulate  other
important factors involved in angiogenesis such as decreasing
MMPs and VEGF by suppressing extracellular MMP inducer
(EMMPRIN) expression [44-47], which should be clarified in
future research.
PSP has been proven to possess multiple bioactivities
including  inhibition  of  tumor  invasion  and  antiviral,
antioxidant, chemoprotective and radioprotective properties
[21,48-51]. To our knowledge, this study demonstrates for the
first  time  that  PSP  has  a  strong  inhibitory  effect  on
inflammation-induced  corneal  neovascularization,  which
suggest  the  potential  use  of  PSP  in  the  treatment  of
inflammatory neovascularization-related corneal diseases. At
present,  the  commonly  used  drugs  to  inhibit
neovascularization in clinical are Avastin and Lucentis, which
has  been  proven  successful  to  treat  choroidal
Figure 9. The effects of PSP on AKT and ERK1/2 signaling. The
protein expression of phosphorylation and total AKT and ERK1/2
were assessed using total cellular protein lysates. PSP significantly
reduced the level of phosphorylation of both AKT and ERK1/2 in
HUVECs, although it had no effect on the total amount of AKT or
ERK1/2 protein.
Figure 8. Effect of PSP on HUVEC tube
formation. HUVECs were plated on the
surface of Matrigel in complete media
with 10, 50, or 100 µg/ml of PSP or
without PSP, and tube formation was
evaluated  6  h  later.  The  angiogenic
stuctures  was  inhibited  by  PSP
obviously  especially  above
concentration  of  50  µg/ml.  One
representative  experiment  of  three
separate assays is shown.
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1958neovascularization  in  age-related  and  myopic  macular
degeneration [52,53]. But considering the price, Avastin and
Lucentis are too expensive for lower-income patients. PSP
may be become a far cheaper alternative drug for the therapy
of  corneal  neovascularization,  although  many  basic  and
clinical trials must be first conducted to confirm its clinical
efficacy and safety before its widespread clinical application.
Further studies should focus on the possible toxicity and side
effects of PSP associated with potential ocular applications.
ACKNOWLEDGMENTS
This work was supported by the Key Science and Technology
Foundation of Shandong Province (2006GG1102020), 973
Programs (2007CB516705), and the fund of the Academy of
Medical Science of Shandong (2006–39). We also appreciate
the help provided by Meili Gao and Yan Gao with the animal
experiments.
REFERENCES
1. Chang  JH,  Gabison  EE,  Kato  T,  Azar  DT.  Corneal
neovascularization. Curr Opin Ophthalmol 2001; 12:242-9.
[PMID: 11507336]
2. Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T,
Albuquerque  RJ,  Richter  E,  Sakurai  E,  Newcomb  MT,
Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A,
Samuelson  DA,  Agnew  DW,  St  Leger  J,  Green  WR,
Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper
LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M,
Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi
JZ,  Raisler  BJ,  Ambati  J.  Corneal  avascularity  is  due  to
soluble VEGF receptor-1. Nature 2006; 443:993-7. [PMID:
17051153]
3. Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid
S, Pytowski B, Persaud K, Wu Y, Streilein JW, Dana R.
Nonvascular  VEGF  receptor  3  expression  by  corneal
epithelium maintains avascularity and vision. Proc Natl Acad
Sci USA 2006; 103:11405-10. [PMID: 16849433]
4. Azar  DT.  Corneal  angiogenic  privilege:  angiogenic  and
antiangiogenic  factors  in  corneal  avascularity,
vasculogenesis,  and  wound  healing  (an  American
Ophthalmological Society thesis). Trans Am Ophthalmol Soc
2006; 104:264-302. [PMID: 17471348]
5. Dawson  DW,  Volpert  OV,  Gillis  P,  Crawford  SE,  Xu  H,
Benedict W, Bouck NP. Pigment epithelium-derived factor:
a potent inhibitor of angiogenesis. Science 1999; 285:245-8.
[PMID: 10398599]
6. Wu  FT,  Stefanini  MO,  Mac  Gabhann  F,  Popel  AS.  A
compartment model of VEGF distribution in humans in the
presence of soluble VEGF receptor-1 acting as a ligand trap.
PLoS One 2009; 4:e5108. [PMID: 19352513]
7. Qazi Y, Wong G, Monson B, Stringham J, Ambati BK. Corneal
transparency: Genesis, maintenance and dysfunction. Brain
Res Bull. 2009 [PMID: 19481138]
8. Lee P, Wang CC, Adamis AP. Ocular neovascularization. An
epidemiologic review. Surv Ophthalmol 1998; 43:245-69.
[PMID: 9862312]
9. Lu  P,  Li  L,  Mukaida  N,  Zhang  X.  Alkali-induced  corneal
neovascularization  is  independent  of  CXCR2-mediated
neutrophil  infiltration.  Cornea  2007;  26:199-206.  [PMID:
17251813]
10. Auerbach  R,  Lewis  R,  Shinners  B,  Kubai  L,  Akhtar  N.
Angiogenesis assays: a critical overview. Clin Chem 2003;
49:32-40. [PMID: 12507958]
11. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M,
Santoni A, Capogrossi MC, Napolitano M. Analysis of the
role  of  chemokines  in  angiogenesis.  J  Immunol  Methods
2003; 273:83-101. [PMID: 12535800]
12. Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane
MP.  CXC  chemokines  in  angiogenesis.  Cytokine  Growth
Factor Rev 2005; 16:593-609. [PMID: 16046180]
13. Ruiz Flores LE, Madrigal-Bujaidar E, Salazar M, Chamorro G.
Anticlastogenic effect of Spirulina maxima extract on the
micronuclei induced by maleic hydrazide in Tradescantia.
Life Sci 2003; 72:1345-51. [PMID: 12527032]
14. Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T.
Activation of the human innate immune system by Spirulina:
augmentation of interferon production and NK cytotoxicity
by  oral  administration  of  hot  water  extract  of  Spirulina
platensis.  Int  Immunopharmacol  2002;  2:423-34.  [PMID:
11962722]
15. Kulshreshtha  A,  Zacharia  AJ,  Jarouliya  U,  Bhadauriya  P,
Prasad GB, Bisen PS. Spirulina in health care management.
Curr Pharm Biotechnol 2008; 9:400-5. [PMID: 18855693]
16. KarkosPDLeongSCKarkosCDSivajiNAssimakopoulosDASpi
rulina  in  Clinical  Practice:  Evidence-Based  Human
Applications.Evid  Based  Complement  Alternat
Med2008[Epub ahead of print] [PubMed: 18955364]
17. Rasool M, Sabina EP, Lavanya B. Anti-inflammatory effect of
Spirulina fusiformis on adjuvant-induced arthritis in mice.
Biol Pharm Bull 2006; 29:2483-7. [PMID: 17142986]
18. Qureshi MA, Garlich JD, Kidd MT. Dietary Spirulina platensis
enhances humoral and cell-mediated immune functions in
chickens.  Immunopharmacol  Immunotoxicol  1996;
18:465-76. [PMID: 8872497]
19. Rasool  M,  Sabina  EP.  Appraisal  of  immunomodulatory
potential of Spirulina fusiformis: an in vivo and in vitro study.
Nat Med (Tokyo) 2008; 63:169-75. [PMID: 19093070]
20. Dartsch  PC.  Antioxidant  potential  of  selected  Spirulina
platensis  preparations.  Phytother  Res  2008;  22:627-33.
[PMID: 18398928]
21. Zhang HQ, Lin AP, Sun Y, Deng YM. Chemo- and radio-
protective effects of polysaccharide of Spirulina platensis on
hemopoietic system of mice and dogs. Acta Pharmacol Sin
2001; 22:1121-4. [PMID: 11749812]
22. Avdagić  N,  Cosović  E,  Nakas-Ićindić  E,  Mornjaković  Z,
Zaciragić A, Hadzović-Dzuvo A. Spirulina platensis protects
against renal injury in rats with gentamicin-induced acute
tubular  necrosis.  Bosn  J  Basic  Med  Sci  2008;  8:331-6.
[PMID: 19125703]
23. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato
RJ. A model of angiogenesis in the mouse cornea. Invest
Ophthalmol Vis Sci 1996; 37:1625-32. [PMID: 8675406]
24. Lyons AB. Analysing cell division in vivo and in vitro using
flow  cytometric  measurement  of  CFSE  dye  dilution.  J
Immunol Methods 2000; 243:147-54. [PMID: 10986412]
25. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T,
Montesano R, Schweigerer L. Genistein, a dietary-derived
Molecular Vision 2009; 15:1951-1961 <http://www.molvis.org/molvis/v15/a208> © 2009 Molecular Vision
1959inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA
1993; 90:2690-4. [PMID: 7681986]
26. González RP, Soares FS, Farias RF, Pessoa C, Leyva A, de
Barros Viana GS, Moraes MO. Demonstration of inhibitory
effect of oral shark cartilage on basic fibroblast growth factor-
induced angiogenesis in the rabbit cornea. Biol Pharm Bull
2001; 24:151-4. [PMID: 11217082]
27. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT,
Fisher C, Flynn E, Byers HR. Curcumin is an in vivo inhibitor
of  angiogenesis.  Mol  Med  1998;  4:376-83.  [PMID:
10780880]
28. Bian F, Zhang MC, Zhu Y. Inhibitory effect of curcumin on
corneal  neovascularization  in  vitro  and  in  vivo.
Ophthalmologica 2008; 222:178-86. [PMID: 18497527]
29. Keshavarz M, Mostafaie A, Mansouri K, Shakiba Y, Motlagh
HR. Inhibition of corneal neovascularization with propolis
extract. Arch Med Res 2009; 40:59-61. [PMID: 19064129]
30. Shiojima  I,  Walsh  K.  Role  of  Akt  signaling  in  vascular
homeostasis and angiogenesis. Circ Res 2002; 90:1243-50.
[PMID: 12089061]
31. Chen  J,  Somanath  PR,  Razorenova  O,  Chen  WS,  Hay  N,
Bornstein  P,  Byzova  TV.  Akt1  regulates  pathological
angiogenesis, vascular maturation and permeability in vivo.
Nat Med 2005; 11:1188-96. [PMID: 16227992]
32. Somanath PR, Razorenova OV, Chen J, Byzova TV. Akt1 in
endothelial cell and angiogenesis. Cell Cycle 2006; 5:512-8.
[PMID: 16552185]
33. Shankar S, Chen Q, Srivastava RK. Inhibition of PI3K/AKT
and  MEK/ERK  pathways  act  synergistically  to  enhance
antiangiogenic effects of EGCG through activation of FOXO
transcription  factor.  J  Mol  Signal  2008;  3:7.  [PMID:
18355401]
34. Huang C, Jacobson K, Schaller MD. MAP kinases and cell
migration. J Cell Sci 2004; 117:4619-28. [PMID: 15371522]
35. Chung BH, Kim JD, Kim CK, Kim JH, Won MH, Lee HS, Dong
MS,  Ha  KS,  Kwon  YG,  Kim  YM.  Icariin  stimulates
angiogenesis by activating the MEK/ERK- and PI3K/Akt/
eNOS-dependent signal pathways in human endothelial cells.
Biochem Biophys Res Commun 2008; 376:404-8. [PMID:
18789310]
36. Montezuma SR, Vavvas D, Miller JW. Review of the ocular
angiogenesis  animal  models.  Semin  Ophthalmol  2009;
24:52-61. [PMID: 19373687]
37. Schwartz S, George J, Ben-Shoshan J, Luboshits G, Avni I,
Levkovitch-Verbin  H,  Ziv  H,  Rosner  M,  Barak  A.  Drug
modification of angiogenesis in a rat cornea model. Invest
Ophthalmol Vis Sci 2008; 49:250-4. [PMID: 18172099]
38. Wu PC, Yang LC, Kuo HK, Huang CC, Tsai CL, Lin PR, Wu
PC, Shin SJ, Tai MH. Inhibition of corneal angiogenesis by
local  application  of  vasostatin.  Mol  Vis  2005;  11:28-35.
[PMID: 15660022]
39. Saika  S,  Miyamoto  T,  Yamanaka  O,  Kato  T,  Ohnishi  Y,
Flanders  KC,  Ikeda  K,  Nakajima  Y,  Kao  WW,  Sato  M,
Muragaki  Y,  Ooshima  A.  Therapeutic  effect  of  topical
administration  of  SN50,  an  inhibitor  of  nuclear  factor-
kappaB, in treatment of corneal alkali burns in mice. Am J
Pathol 2005; 166:1393-403. [PMID: 15855640]
40. DeStafeno JJ, Kim T. Topical bevacizumab therapy for corneal
neovascularization.  Arch  Ophthalmol  2007;  125:834-6.
[PMID: 17562998]
41. Kim SW, Ha BJ, Kim EK, Tchah H, Kim TI. The effect of
topical  bevacizumab  on  corneal  neovascularization.
Ophthalmology 2008; 115:e33-8. [PMID: 18439681]
42. Lima e Silva R, Shen J, Hackett SF, Kachi S, Akiyama H, Kiuchi
K, Yokoi K, Hatara MC, Lauer T, Aslam S, Gong YY, Xiao
WH, Khu NH, Thut C, Campochiaro PA. The SDF-1/CXCR4
ligand/receptor pair is an important contributor to several
types  of  ocular  neovascularization.  FASEB  J  2007;
21:3219-30. [PMID: 17522382]
43. Chen JX, Chen Y, DeBusk L, Lin W, Lin PC. Dual functional
roles  of  Tie-2/angiopoietin  in  TNF-alpha-mediated
angiogenesis.  Am  J  Physiol  Heart  Circ  Physiol  2004;
287:H187-95. [PMID: 15210451]
44. Gabison EE, Huet E, Baudouin C, Menashi S. Direct epithelial-
stromal  interaction  in  corneal  wound  healing:  Role  of
EMMPRIN/CD147 in MMPs induction and beyond. Prog
Retin Eye Res 2009; 28:19-33. [PMID: 19056510]
45. Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty
P, Bugelski P, Yan L. Extracellular matrix metalloproteinase
inducer stimulates tumor angiogenesis by elevating vascular
endothelial cell growth factor and matrix metalloproteinases.
Cancer Res 2005; 65:3193-9. [PMID: 15833850]
46. Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa
S, Tsuneyama K, Takano Y. Upregulated EMMPRIN/CD147
might  contribute  to  growth  and  angiogenesis  of  gastric
carcinoma: a good marker for local invasion and prognosis.
Br J Cancer 2006; 95:1371-8. [PMID: 17088917]
47. Voigt  H,  Vetter-Kauczok  CS,  Schrama  D,  Hofmann  UB,
Becker  JC,  Houben  R.  CD147  impacts  angiogenesis  and
metastasis  formation.  Cancer  Invest  2009;  27:329-33.
[PMID: 19160100]
48. Remirez D, González R, Merino N, Rodriguez S, Ancheta O.
Inhibitory effects of Spirulina in zymosan-induced arthritis in
mice. Mediators Inflamm 2002; 11:75-9. [PMID: 12061427]
49. Mishima T, Murata J, Toyoshima M, Fujii H, Nakajima M,
Hayashi T, Kato T, Saiki I. Inhibition of tumor invasion and
metastasis  by  calcium  spirulan  (Ca-SP),  a  novel  sulfated
polysaccharide  derived  from  a  blue-green  alga,  Spirulina
platensis.  Clin  Exp  Metastasis  1998;  16:541-50.  [PMID:
9872601]
50. Hayashi  K,  Hayashi  T,  Kojima  I.  A  natural  sulfated
polysaccharide,  calcium  spirulan,  isolated  from  Spirulina
platensis:  in  vitro  and  ex  vivo  evaluation  of  anti-herpes
simplex  virus  and  anti-human  immunodeficiency  virus
activities. AIDS Res Hum Retroviruses 1996; 12:1463-71.
[PMID: 8893054]
51. Hayashi T, Hayashi K, Maeda M, Kojima I. Calcium spirulan,
an inhibitor of enveloped virus replication, from a blue-green
alga Spirulina platensis. J Nat Prod 1996; 59:83-7. [PMID:
8984158]
52. Fine HF, Zhitomirsky I, Freund KB, Barile GR, Shirkey BL,
Samson  CM,  Yannuzzi  LA.  Bevacizumab  (avastin)  and
ranibizumab (lucentis) for choroidal neovascularization in
multifocal  choroiditis.  Retina  2009;  29:8-12.  [PMID:
18784620]
53. Landa G, Amde W, Doshi V, Ali A, McGevna L, Gentile RC,
Muldoon TO, Walsh JB, Rosen RB. Comparative Study of
Intravitreal  Bevacizumab  (Avastin)  versus  Ranibizumab
(Lucentis)  in  the  Treatment  of  Neovascular  Age-Related
Molecular Vision 2009; 15:1951-1961 <http://www.molvis.org/molvis/v15/a208> © 2009 Molecular Vision
1960Macular Degeneration. Ophthalmologica 2009; 223:370-5.
[PMID: 19590252]
Molecular Vision 2009; 15:1951-1961 <http://www.molvis.org/molvis/v15/a208> © 2009 Molecular Vision
The print version of this article was created on 21 September 2009. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
1961